BI
IDXX icon

BlueSpruce Investments’s Idexx Laboratories IDXX Stock Holding History

BlueSpruce Investments’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,053
Closed -$1.1M – 36
2025
Q2 		$1.1M Hold
2,053
– – 0.03% 15
2025
Q1 		$862K Buy
2,053
+537
+35% +$233K 0.02% 12
2024
Q4 		$627K Hold
1,516
– – 0.01% 25
2024
Q3 		$766K Hold
1,516
– – 0.01% 20
2024
Q2 		$739K Buy
+1,516
New +$761K 0.01% 18

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

BlueSpruce Investments's IDXX Position: Q3 2025 in Review

BlueSpruce Investments sold out of Idexx Laboratories (IDXX) in Q3 2025, closing a stake of 2,053 shares — an estimated $1.1M sold.

BlueSpruce Investments first reported a position in IDXX in Q2 2024 and held it in 5 quarters. The position peaked at $1.1M in Q2 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q3 2025.

  • BlueSpruce Investments reported no remaining Idexx Laboratories position as of Q3 2025 after selling out during the quarter.
  • BlueSpruce Investments sold 2,053 Idexx Laboratories shares in Q3 2025, an estimated $1.1M.
  • BlueSpruce Investments first reported a position in Idexx Laboratories in Q2 2024 and held it in 5 quarters.
  • BlueSpruce Investments's Idexx Laboratories position peaked at $1.1M in Q2 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2025.

Based on BlueSpruce Investments's 13F filing for Q3 2025, filed 14 Nov 2025.